We are live on ! Find out more
RBC

Roble Belko & Company Portfolio holdings

AUM $925M
1-Year Est. Return 19.7%
This Fund
S&P 500
This Quarter Est. Return
+16.84%
1 Year Est. Return
+19.7%
3 Year Est. Return
+53.27%
5 Year Est. Return
+47.85%
10 Year Est. Return
+149.75%
AUM
$334M
AUM Growth
+$24.3M
Cap. Flow
-$24.6M
Cap. Flow %
-7.37%
Top 10 Hldgs %
54.8%
Holding
349
New
15
Increased
35
Reduced
73
Closed
25

Top Buys

Rank Stock Value
1
SDY icon
State Street SPDR S&P Dividend ETF
SDY
+$3.69M
2
VNQ icon
Vanguard Real Estate ETF
VNQ
+$3.33M
3
VIGI icon
Vanguard International Dividend Appreciation ETF
VIGI
+$3.18M
4
JPST icon
JPMorgan Ultra-Short Income ETF
JPST
+$2.35M
5
VXF icon
Vanguard Extended Market ETF
VXF
+$406K

Top Sells

Rank Stock Value
1
VYMI icon
Vanguard International High Dividend Yield ETF
VYMI
+$5.4M
2
SCHH icon
Schwab US REIT ETF
SCHH
+$3.35M
3
IWB icon
iShares Russell 1000 ETF
IWB
+$3.11M
4
VOO icon
Vanguard S&P 500 ETF
VOO
+$2.73M
5
VTI icon
Vanguard Morningstar Total Stock Market ETF
VTI
+$2.67M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 1.99%
2 Technology 1.72%
3 Healthcare 0.91%
4 Industrials 0.77%
5 Financials 0.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XLY icon
151
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$22.9B
$41K 0.01%
646
– –
BND icon
152
Vanguard Total Bond Market
BND
$157B
$40K 0.01%
450
-124
-22% -$10.8K
MU icon
153
Micron Technology
MU
$996B
$38K 0.01%
744
– –
BR icon
154
Broadridge
BR
$18.8B
$37K 0.01%
295
– –
HUBB icon
155
Hubbell
HUBB
$26.8B
$37K 0.01%
+295
New +$35.9K
SCHD icon
156
Schwab US Dividend Equity ETF
SCHD
$105B
$37K 0.01%
2,151
-1,431
-40% -$24.2K
SLB icon
157
SLB Ltd
SLB
$76.5B
$37K 0.01%
+2,000
New +$35K
UL icon
158
Unilever
UL
$137B
$36K 0.01%
588
-127
-18% -$7.59K
GSK icon
159
GSK
GSK
$104B
$35K 0.01%
686
– –
NVS icon
160
Novartis
NVS
$293B
$35K 0.01%
405
– –
BAC icon
161
Bank of America
BAC
$441B
$34K 0.01%
1,423
– –
CWB icon
162
State Street SPDR Bloomberg Convertible Securities ETF
CWB
$5.64B
$34K 0.01%
555
– –
IVOO icon
163
Vanguard S&P Mid-Cap 400 ETF
IVOO
$3.78B
$34K 0.01%
560
– –
BMY icon
164
Bristol-Myers Squibb
BMY
$131B
$33K 0.01%
561
+250
+80% +$15K
ETSY icon
165
Etsy
ETSY
$7.81B
$32K 0.01%
300
– –
PAYC icon
166
Paycom
PAYC
$10.1B
$32K 0.01%
102
– –
VIOO icon
167
Vanguard S&P Small-Cap 600 ETF
VIOO
$4.22B
$31K 0.01%
500
– –
VHT icon
168
Vanguard Health Care ETF
VHT
$18.4B
$30K 0.01%
155
– –
DBEF icon
169
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
$9.33B
$29K 0.01%
965
-527
-35% -$15.3K
IBB icon
170
iShares Biotechnology ETF
IBB
$9.53B
$29K 0.01%
212
– –
JPM icon
171
JPMorgan Chase
JPM
$947B
$29K 0.01%
304
– –
NEA icon
172
Nuveen AMT-Free Quality Municipal Income Fund
NEA
$3.39B
$29K 0.01%
2,078
-3,333
-62% -$45K
AZN icon
173
AstraZeneca
AZN
$250B
$28K 0.01%
260
– –
BURL icon
174
Burlington
BURL
$23.4B
$28K 0.01%
143
– –
MKTX icon
175
MarketAxess Holdings
MKTX
$5.72B
$28K 0.01%
55
– –
5 6
7
8 9

Similar funds

ICM
Innovator Capital Management Wheaton, Illinois $925M AUM 49.11% 1-Year Est. Return
TC
Tairen Capital Hong Kong $924M AUM 105.21% 1-Year Est. Return
CFA
Cahill Financial Advisors Edina, Minnesota $924M AUM 16.55% 1-Year Est. Return
MHIC
Marble Harbor Investment Counsel Boston, Massachusetts $923M AUM 14.09% 1-Year Est. Return
GFG
Goldstone Financial Group Oakbrook Terrace, Illinois $922M AUM 14.34% 1-Year Est. Return
KI
Koch Inc Wichita, Kansas $922M AUM 16.65% 1-Year Est. Return
WC
Westerkirk Capital Victoria $929M AUM 21.93% 1-Year Est. Return
BCC
Biglari Capital Corp San Antonio, Texas $929M AUM 39.8% 1-Year Est. Return

Roble Belko & Company's Q2 2020 Portfolio in Review

As of Q2 2020, Roble Belko & Company held 349 positions worth $334M, up 7.9% from $309M the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Roble Belko & Company withdrew a net $24.6M in Q2 2020, closing 25 positions and reducing 73 holdings. Its most notable exit was Vanguard International High Dividend Yield ETF, an estimated $5.4M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 2% of assets, down from 2% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Roble Belko & Company opened a new position in iShares iBonds Dec 2028 Term Corporate ETF worth $262K.

  • Roble Belko & Company's largest Q2 2020 buy was iShares iBonds Dec 2028 Term Corporate ETF: 9,096 shares worth $262K.
  • Roble Belko & Company added most to State Street SPDR S&P Dividend ETF in Q2 2020, an estimated $3.69M increase.
  • Roble Belko & Company's biggest Q2 2020 reduction was Schwab US REIT ETF, cutting an estimated $3.35M.
  • Roble Belko & Company fully exited Vanguard International High Dividend Yield ETF in Q2 2020, selling an estimated $5.4M.
  • Roble Belko & Company's ten largest holdings make up 55% of its $334M portfolio in Q2 2020.
  • Roble Belko & Company opened 15 new positions and closed 25 in Q2 2020.
  • Roble Belko & Company's portfolio value rose 7.9% quarter-over-quarter to $334M.

Based on Roble Belko & Company's 13F filing for Q2 2020, filed 10 Aug 2020.